Developer docs
API playgroundTry for free, no card

Search company profiles

Groupe Bruxelles Lambert

Full company profile

uuid003f4hq

Namestring
Groupe Bruxelles Lambert
Legal namestring
Groupe Bruxelles Lambert S.A.
Websiteurl
gbl.be
Company typeenum
Public
Founded yearint
1956
Descriptiontext

Groupe Bruxelles Lambert (GBL) is a Brussels-headquartered investment holding company, listed on Euronext Brussels under ticker GBL with over 70 years of continuous stock exchange listing. As of 31 March 2026, GBL reported a net asset value of €13.3 billion, a portfolio value of €11.1 billion, and a market capitalization of €10 billion, supported by a stable multigenerational family shareholder base that underwrites its long-term investment horizon.

GBL operates a single investment platform organised across three segments: Listed Assets (52% of portfolio) holding minority stakes in adidas, Concentrix, Imerys, Ontex, Pernod Ricard, and SGS; Direct Private Assets (37% of portfolio) encompassing co-controlled or wholly-owned positions in Affidea, Canyon, Parques Reunidos, Sanoptis, and Voodoo; and GBL Capital (10% of portfolio), a non-core vehicle for indirect private assets. GBL generates returns through dividends, capital appreciation, and selective co-control transactions executed alongside private-equity partners such as CVC Capital Partners, with a notable recent emphasis on healthcare (Rayner, Sanoptis, and the pending €10.7 billion Recordati privatisation).

GBL's revenue mechanics differ from operating companies: income derives from portfolio dividend streams, realised capital gains on divestitures (e.g., the 2025–2026 full exit of Umicore), and consolidated subsidiary contributions. The company maintains a 6.4% dividend yield as of March 2026 and has offices in Brussels, London, Luxembourg, Milan, Munich, and Paris to support cross-European deal sourcing and portfolio oversight.

Short descriptiontext

Groupe Bruxelles Lambert is a Brussels-listed investment holding company managing a €13.3 billion portfolio across listed assets (52%), direct private assets (37%), and non-core vehicles (10%), serving as long-term shareholder in European companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment holding, portfolio management, long-term equity investment, private equity, asset management
Industry1 code
1Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory)
CodeBPAHAOALPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Investment Holding Company
No data
Revenue model1 record
1Investment returns and capital appreciation
TypeLicensing Royalties
Description

GBL generates returns through long-term investments in listed and private assets, including dividends, capital gains, and portfolio value appreciation. The company maintains a net asset value of €13 billion and portfolio value of €11.1 billion as of March 2026.

gbl.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1GBL Capital
Description

Non-core asset class management platform handling indirect private assets (10% of portfolio)

gbl.com
Core offering1 text field

Groupe Bruxelles Lambert is an investment holding company that deploys patient long-term capital across a diversified European portfolio of listed equities and direct private assets. It generates returns through minority stakes in public companies, co-controlling positions in private businesses, and indirect private asset investments via its GBL Capital arm, with a portfolio value of €11.1 billion as of March 2026.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Groupe Bruxelles Lambert (GBL) is an established investment holding company with over seventy years of stock exchange listing, a net asset value of €13.3 billion and a market capitalization of €10 billion as of March 2026. GBL operates as a single unified investment platform structured around three core portfolio segments: (1) Listed Assets (52% of portfolio) encompassing stakes in adidas, Concentrix, Imerys, Ontex, Pernod Ricard, and SGS; (2) Direct Private Assets (37% of portfolio) including Affidea, Canyon, Parques Reunidos, Sanoptis, and Voodoo; and (3) GBL Capital (10% of portfolio) for indirect private assets and secondary market investments. GBL's investment strategy focuses on long-term value creation with a stable family shareholder base, maintaining an attractive dividend yield of 6.4%.

Product and service3 records
1Listed Assets Portfolio
CategoryInvestment Portfolio
Description

Minority equity stakes in listed European companies including adidas, Concentrix, Imerys, Ontex, Pernod Ricard and SGS, representing 52% of GBL's total portfolio value and held as long-term investments.

2Direct Private Assets Portfolio
CategoryPrivate Equity Portfolio
Description

Co-controlled and directly held private European companies including Affidea (healthcare), Canyon (bicycles), Parques Reunidos (leisure parks), Sanoptis (eye care) and Voodoo (mobile gaming), representing 37% of GBL's total portfolio.

3GBL Capital - Non-Core Asset Class Program
CategoryIndirect Private Investments
Description

Indirect private assets and secondary market investments program operated through GBL Capital, focusing on non-core asset classes and representing 10% of GBL's total portfolio.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish listed investment holding with a portfolio of significant minority stakes in large Nordic listed industrials; mirrors GBL's listed-minority-orientation and stable shareholder base.

TypeDirect peer
Description

Swedish investment holding company controlled by the Wallenberg family with listed and unlisted holdings across industrials, healthcare, and financial services; the most established European listed-holdings analog to GBL.

TypeBroad incumbent
Description

French-listed private investment firm with both majority private-asset and minority listed portfolios; a larger, broader alternative-asset manager that overlaps with GBL's direct private and listed activities.

TypeOthers
Description

Global private-markets manager with ~€205bn AUM that is GBL's most active co-investment partner on Rayner and Recordati; comparable by activity rather than structure.

TypeDirect peer
Description

Belgian investment holding focused on direct private investments and minority listed stakes, also headquartered in Brussels with a similar family-influenced long-term mandate.

TypeDirect peer
Description

Swedish family-controlled investment company with diversified listed and private holdings, including notable consumer-tech and healthcare exposure; similar long-horizon capital allocation philosophy.

TypeDirect peer
Description

French listed investment holding company with long-duration minority and controlling stakes in European industrial and services businesses; comparable diversified long-term holding model.

TypeDirect peer
Description

Dutch-listed investment holding company controlled by the Agnelli family with diversified equity holdings across listed and private assets, structurally analogous to GBL with similar long-horizon family-shareholder model.

TypeDirect peer
Description

Moroccan strategic investment holding with diversified listed and private holdings; serves as a comparable emerging-market family-controlled listed-holdings structure.

TypeBroad incumbent
Description

U.S. conglomerate and investment holding run with multigenerational patient capital; the global benchmark for the family-controlled long-horizon holding model that GBL follows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries14 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Groupe Bruxelles Lambert

Investment Holding Companygbl.be

Groupe Bruxelles Lambert is a Brussels-listed investment holding company managing a €13.3 billion portfolio across listed assets (52%), direct private assets (37%), and non-core vehicles (10%), serving as long-term shareholder in European companies.

What Groupe Bruxelles Lambert does

Groupe Bruxelles Lambert (GBL) is a Brussels-headquartered investment holding company, listed on Euronext Brussels under ticker GBL with over 70 years of continuous stock exchange listing. As of 31 March 2026, GBL reported a net asset value of €13.3 billion, a portfolio value of €11.1 billion, and a market capitalization of €10 billion, supported by a stable multigenerational family shareholder base that underwrites its long-term investment horizon.

GBL operates a single investment platform organised across three segments: Listed Assets (52% of portfolio) holding minority stakes in adidas, Concentrix, Imerys, Ontex, Pernod Ricard, and SGS; Direct Private Assets (37% of portfolio) encompassing co-controlled or wholly-owned positions in Affidea, Canyon, Parques Reunidos, Sanoptis, and Voodoo; and GBL Capital (10% of portfolio), a non-core vehicle for indirect private assets. GBL generates returns through dividends, capital appreciation, and selective co-control transactions executed alongside private-equity partners such as CVC Capital Partners, with a notable recent emphasis on healthcare (Rayner, Sanoptis, and the pending €10.7 billion Recordati privatisation).

GBL's revenue mechanics differ from operating companies: income derives from portfolio dividend streams, realised capital gains on divestitures (e.g., the 2025–2026 full exit of Umicore), and consolidated subsidiary contributions. The company maintains a 6.4% dividend yield as of March 2026 and has offices in Brussels, London, Luxembourg, Milan, Munich, and Paris to support cross-European deal sourcing and portfolio oversight.

Groupe Bruxelles Lambert firmographics

Firmographics
Name
Groupe Bruxelles Lambert
Legal name
Groupe Bruxelles Lambert S.A.
Website
https://gbl.be
Company type
Public
Founded year
1956
Operating status
Operating
Headcount range
101–250 employees
Short description
Groupe Bruxelles Lambert is a Brussels-listed investment holding company managing a €13.3 billion portfolio across listed assets (52%), direct private assets (37%), and non-core vehicles (10%), serving as long-term shareholder in European companies.
Ownership category
akta.pro rank

Groupe Bruxelles Lambert industry classification

Industry
Product category
Investment Holding Company
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro primary industry
Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

Keywords

  • Investment holding
  • Portfolio management
  • Long-term equity investment
  • Private equity
  • Asset management

Where Groupe Bruxelles Lambert is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices6 records

Markets served

Groupe Bruxelles Lambert business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Revenue model

  1. Investment returns and capital appreciation: GBL generates returns through long-term investments in listed and private assets, including dividends, capital gains, and portfolio value appreciation. The company maintains a net asset value of €13 billion and portfolio value of €11.1 billion as of March 2026.

Distribution channels1 record

Marketing channels3 records

Groupe Bruxelles Lambert product offering

Product offering

Core offering

Groupe Bruxelles Lambert is an investment holding company that deploys patient long-term capital across a diversified European portfolio of listed equities and direct private assets. It generates returns through minority stakes in public companies, co-controlling positions in private businesses, and indirect private asset investments via its GBL Capital arm, with a portfolio value of €11.1 billion as of March 2026.

Product overview

Groupe Bruxelles Lambert (GBL) is an established investment holding company with over seventy years of stock exchange listing, a net asset value of €13.3 billion and a market capitalization of €10 billion as of March 2026. GBL operates as a single unified investment platform structured around three core portfolio segments: (1) Listed Assets (52% of portfolio) encompassing stakes in adidas, Concentrix, Imerys, Ontex, Pernod Ricard, and SGS; (2) Direct Private Assets (37% of portfolio) including Affidea, Canyon, Parques Reunidos, Sanoptis, and Voodoo; and (3) GBL Capital (10% of portfolio) for indirect private assets and secondary market investments. GBL's investment strategy focuses on long-term value creation with a stable family shareholder base, maintaining an attractive dividend yield of 6.4%.

Differentiator

Problem solved

Functional benefit

Brands

  • GBL Capital: Non-core asset class management platform handling indirect private assets (10% of portfolio)

Products and services

  • Listed Assets Portfolio Minority equity stakes in listed European companies including adidas, Concentrix, Imerys, Ontex, Pernod Ricard and SGS, representing 52% of GBL's total portfolio value and held as long-term investments.
  • Direct Private Assets Portfolio Co-controlled and directly held private European companies including Affidea (healthcare), Canyon (bicycles), Parques Reunidos (leisure parks), Sanoptis (eye care) and Voodoo (mobile gaming), representing 37% of GBL's total portfolio.
  • GBL Capital - Non-Core Asset Class Program Indirect private assets and secondary market investments program operated through GBL Capital, focusing on non-core asset classes and representing 10% of GBL's total portfolio.

Companies that use Groupe Bruxelles Lambert

Customer profile

Segments1 record

Ideal customer profiles2 records

Groupe Bruxelles Lambert technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Groupe Bruxelles Lambert partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Groupe Bruxelles Lambert competitors and assessment

Company assessment

Direct peers

  • Industrivärden AB: Swedish listed investment holding with a portfolio of significant minority stakes in large Nordic listed industrials; mirrors GBL's listed-minority-orientation and stable shareholder base.
  • Investor AB: Swedish investment holding company controlled by the Wallenberg family with listed and unlisted holdings across industrials, healthcare, and financial services; the most established European listed-holdings analog to GBL.
  • Sofina SA: Belgian investment holding focused on direct private investments and minority listed stakes, also headquartered in Brussels with a similar family-influenced long-term mandate.
  • Kinnevik AB: Swedish family-controlled investment company with diversified listed and private holdings, including notable consumer-tech and healthcare exposure; similar long-horizon capital allocation philosophy.
  • Wendel SE: French listed investment holding company with long-duration minority and controlling stakes in European industrial and services businesses; comparable diversified long-term holding model.
  • Exor N.V. Dutch-listed investment holding company controlled by the Agnelli family with diversified equity holdings across listed and private assets, structurally analogous to GBL with similar long-horizon family-shareholder model.
  • L'Ermitage / Société Nationale d'Investissement: Moroccan strategic investment holding with diversified listed and private holdings; serves as a comparable emerging-market family-controlled listed-holdings structure.

Broad incumbents

  • Eurazeo SE: French-listed private investment firm with both majority private-asset and minority listed portfolios; a larger, broader alternative-asset manager that overlaps with GBL's direct private and listed activities.
  • Berkshire Hathaway: U.S. conglomerate and investment holding run with multigenerational patient capital; the global benchmark for the family-controlled long-horizon holding model that GBL follows.

Others

  • CVC Capital Partners: Global private-markets manager with ~€205bn AUM that is GBL's most active co-investment partner on Rayner and Recordati; comparable by activity rather than structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Groupe Bruxelles Lambert financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Groupe Bruxelles Lambert leadership team

Management profile

Number of profiles

Profiles5 records

Groupe Bruxelles Lambert subsidiaries and ownership

Company hierarchy

Subsidiaries14 records

Groupe Bruxelles Lambert funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Groupe Bruxelles Lambert M&A and investment

M&A and investment

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Groupe Bruxelles Lambert

What does Groupe Bruxelles Lambert do?

Groupe Bruxelles Lambert is an investment holding company that deploys patient long-term capital across a diversified European portfolio of listed equities and direct private assets. It generates returns through minority stakes in public companies, co-controlling positions in private businesses, and indirect private asset investments via its GBL Capital arm, with a portfolio value of €11.1 billion as of March 2026.

Is Groupe Bruxelles Lambert a public or private company?

Groupe Bruxelles Lambert is a public company. It is classified as public and is currently operating.

When was Groupe Bruxelles Lambert founded?

Groupe Bruxelles Lambert was founded in 1956. It employs 101 to 250 people.

Where is Groupe Bruxelles Lambert based?

Groupe Bruxelles Lambert is headquartered in Brussels, Belgium, in the Europe region.

How does Groupe Bruxelles Lambert make money?

One revenue line is on record: investment returns and capital appreciation.

Who are Groupe Bruxelles Lambert's main competitors?

Direct peers on record are Industrivärden AB, Investor AB, Sofina SA, Kinnevik AB, Wendel SE, Exor N.V. and L'Ermitage / Société Nationale d'Investissement. Broad incumbents are Eurazeo SE and Berkshire Hathaway. CVC Capital Partners is listed as an others.

Does Groupe Bruxelles Lambert have an API?

No public API is recorded for Groupe Bruxelles Lambert.

What industry is Groupe Bruxelles Lambert in?

Groupe Bruxelles Lambert's product category is Investment Holding Company. Its primary akta.pro industry code is BPAHAOAL, Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Markets DailyGroupe Bruxelles Lambert (OTCMKTS:GBLBY) Trading 3.2% Higher – Here’s What HappenedShares of Belgian investment holding company Groupe Bruxelles Lambert rose 3.2% to $9.12 during Tuesday trading, with volume declining 60% from the average session to approximately 847 shares. Citigroup maintained a "neutral" rating on the stock, while the company's 50-day and 200-day moving averages stood at $9.52 and $9.62 respectively. The company, established in 1972, manages a diversified portfolio spanning consumer goods, healthcare, energy, materials, and financial services.Simply Wall StGroupe Bruxelles Lambert (ENXTBR:GBLB) Looks Cheap On Half Year Earnings ProgressGroupe Bruxelles Lambert reported half-year 2026 earnings with sales of €3,359.3 million and net income of €53.5 million, alongside higher earnings per share, with the share price at €79.0 showing modest short-term gains and a 1-year total shareholder return of 13.93%. The stock trades at a P/S ratio of 1.4x, significantly below the European Diversified Financial industry average of 2.3x and peer average of 24.5x, suggesting the market is pricing the company at a relative discount to comparable firms. However, the company also reported a net income loss of €300.6 million and a weaker 5-year total return of 5.82%, raising questions about whether the valuation discount reflects underlying financial concerns.MarketScreenerMarketScreenerGroupe Bruxelles Lambert SA is a holding company with a diversified portfolio valued at EUR 12.8 billion, including listed assets, private assets, and indirect private assets. The portfolio includes global leaders in inspection, spirits, sporting goods, mining, diagnostics, and ophthalmology.Quiver Quantitative$CNXC stock is up 13% today. Here's what we see in our data. | Quiver Quantitative$CNXC stock rose 13% on July 13, 2026, with approximately $31.5 million in trading volume, ranking as the 395th most-searched ticker on Quiver Quantitative out of 14,211 total tickers. Insider trading data shows Bruxelles Lambert Groupe sold 6 million shares for $133.5 million, while President and CEO Christopher Caldwell and CFO Andre Valentine made purchases totaling approximately $155,000. Hedge fund activity in Q1 2026 saw 155 institutional investors adding positions and 144 decreasing holdings, with notable increases from UBS Group AG, AQR Capital Management, and Citadel Advisors, while analyst price targets range from $26 to $45.Les EchosSienna Private Equity recompose son actionnariatSienna Private Equity and GBL separate from Groupe Bruxelles Lambert, but the Frère family remains involved through two other investment vehicles. The founders are supported by Compagnie Nationale à Portefeuille, family office FG Bros, and Impala.WsjFinancial Services Roundup: Market TalkCVC Capital Partners and Groupe Bruxelles Lambert have launched a 10.73 billion euro bid to take Italian pharmaceutical company Recordati private. The consortium aims to acquire at least two-thirds of the share capital, with CVC committing its entire 46.8% stake through a new fund while GBL contributes 1.3 billion euros. Analysts view the move as strategic for Recordati's R&D needs but note the high leverage and risk involved for the investors.Endpoints NewsTen­der of­fer for Recor­dati; So­bi's gout drug pass­es Phase 3 testCVC Capital Partners and Groupe Bruxelles Lambert launched a voluntary cash tender offer for Italian drugmaker Recorati at €51.29 per share, potentially valuing the company at over $12 billion. Meanwhile, Sobi reported that its gout drug pozdeutinurad met the primary endpoint in its Phase 3 REDUCE 2 trial, with nearly 70% of patients achieving target uric acid levels.WsjCVC Teams Up With GBL for $12.5 Billion Bid to Take Recordati PrivateCVC Capital Partners and Groupe Bruxelles Lambert announced a joint bid to take Recordati private, valuing the Italian drugmaker at 10.73 billion euros ($12.47 billion). The bid follows CVC's takeover approach earlier this year and could rank among Europe's biggest healthcare deals.MarketScreenerHealth Care Up on Deal Activity - Health Care RoundupHealth-care stocks rose on deal activity and demand for inflation-resistant sectors. CVC Capital Partners and Groupe Bruxelles Lambert bid $12.47 billion to take Recordati private, while Novo Nordisk rose after the European Medicines Agency recommended Wegovy approval.BeBeezRecordati, CVC Capital Partners si allea con Groupe Bruxelles Lambert per lanciare l'opa totalitaria da 10,7 mld euro - BeBeezCVC Capital Partners and Groupe Bruxelles Lambert announced a total takeover offer for Recordati at 51.29 euros per share, valuing the company at a maximum of 10.7 billion euros. The offer, which includes CPP Investment Board, PSP Europe, and others, is expected to close in Q4 2026, subject to a 66.67% capital threshold.